OnabotulinumtoxinA for chronic migraine: a real-life Italian multicenter experience

Neurol Sci. 2018 Jun;39(Suppl 1):171-172. doi: 10.1007/s10072-018-3393-3.
No abstract available

Publication types

  • Multicenter Study

MeSH terms

  • Adult
  • Botulinum Toxins, Type A / therapeutic use*
  • Chronic Disease / drug therapy
  • Female
  • Humans
  • Italy
  • Male
  • Middle Aged
  • Migraine Disorders / drug therapy*
  • Neuromuscular Agents / therapeutic use*
  • Retrospective Studies
  • Time Factors

Substances

  • Neuromuscular Agents
  • Botulinum Toxins, Type A